Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

411
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invited Commentary: Early Detection of Pancreatic Cancer: Are We Up for the Challenge?

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Prevalence and Clinical Significance of Abnormal Findings on Pre-Diagnostic Imaging in Pancreatic Ductal Adenocarcinoma.

Pancreas·2026
Same author

Hierarchical organ aging signatures from routine abdominal CT add incremental disease risk stratification beyond blood biomarkers.

medRxiv : the preprint server for health sciences·2026
Same author

Multimodal AI for early prediction of adverse clinical outcomes in acute pancreatitis.

Abdominal radiology (New York)·2026
Same author

The role of MRCP in characterizing ductal communication and high-risk features in pancreatic cystic lesions.

Abdominal radiology (New York)·2026
Same author

Correction to: Multi-center evaluation of radiomics and deep learning to stratify malignancy risk of IPMNs.

Abdominal radiology (New York)·2026
Same journal

Prospective study of ASL and T1-mapping to assess renal function at different stages of early graft dysfunction from renal transplantation.

Abdominal radiology (New York)·2026
Same journal

Peribiliary cysts on MRI: review of imaging features and associated clinical features.

Abdominal radiology (New York)·2026
Same journal

When intelligence meets radiology: the dual impact of ai on radiologists' workload, burnout, and economic value.

Abdominal radiology (New York)·2026
Same journal

Detection of hypodense hepatic and renal lesions on abdominal CT reconstructed with deep learning image reconstruction technique in patients with large body habitus: A multi-reader study.

Abdominal radiology (New York)·2026
Same journal

When the appendix hides: the radiologist's guide to appendix variants and mimics.

Abdominal radiology (New York)·2026
Same journal

Multimodality staging of renal cell carcinoma-pearls & pitfalls.

Abdominal radiology (New York)·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

544

Pancreatic cancer screening.

Chris M Lindquist1, Frank H Miller2, Nancy A Hammond2

  • 1Department of Radiology, Faculty of Medicine, St. Boniface General Hospital, University of Manitoba, 409 Tache Ave, Winnipeg, MB, R2H 2A6, Canada. chrislindquist1@gmail.com.

Abdominal Radiology (New York)
|August 26, 2017
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer screening shows promise for detecting early disease and precursor lesions in high-risk individuals. Further research is needed to clarify the exact mortality benefit of these screening strategies.

Keywords:
EUSFamilial pancreatic cancerMRIPancreatic adenocarcinoma screeningPancreatic cancer screeningPancreatic cancer screening guidelines

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

770

Related Experiment Videos

Last Updated: Feb 24, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

544
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

770

Area of Science:

  • Gastroenterology and Oncology
  • Medical Screening Protocols

Background:

  • Pancreatic cancer has a low incidence in the general population.
  • Early detection of pancreatic adenocarcinoma and precursor lesions is crucial for improved outcomes.
  • High-risk individuals, identified by family history or genetic syndromes, are the primary focus for screening.

Purpose of the Study:

  • To review current evidence on pancreatic cancer screening.
  • To identify targets for screening, including early cancer and precursor lesions like intraductal papillary mucinous neoplasm and high-grade pancreatic intraepithelial neoplasia.

Main Methods:

  • Extensive literature review of available studies on pancreatic screening.
  • Summary of findings from prospective trials evaluating screening in high-risk groups.
  • Discussion of current consensus guidelines and recommendations.

Main Results:

  • Prospective trials have focused on screening high-risk populations.
  • Evidence suggests a window for detecting precursor lesions and early pancreatic adenocarcinomas.
  • Consensus guidelines and recommendations from international summits are considered.

Conclusions:

  • The definitive benefit of pancreatic cancer screening is still under investigation.
  • Emerging evidence supports the potential for early detection in high-risk groups.
  • Improved understanding of carcinogenesis may enhance detection of resectable tumors and reduce mortality.